Call (919) 782-5911
Select Page

Tammy Enders, RN,BSN,OCN and Gestational Carrier Coordinator @ Carolina Conceptions

Carolina Conceptions is proud to be one of the approximately 25-30 fertility clinics nationwide currently participating in the Ferring MEGASET-HR clinical trial comparing two IVF medications used for controlled ovarian stimulation. Both medications are approved by the FDA (U.S. Food & Drug Administration) and are administered via subcutaneous injections to stimulate the growth of follicles and eggs in the ovaries of an IVF patient. We were selected to participate in the study due to our highly successful IVF and embryo biopsy programs.

This is an exciting opportunity for qualified IVF patients because participants will also receive FREE medication for one fresh IVF cycle, and PGS testing (Preimplantation Genetic Screening) of their embryos. One healthy embryo will be transferred into the uterus of the patient in hopes of achieving pregnancy.

Study participants will also receive a significant price reduction for the IVF cycle fee that Carolina Conceptions charges. In exchange for these perks, the patient needs to be compliant with all requirements of the trial, and must come to Carolina Conceptions for all testing (ultrasound scans and bloodwork). Please contact a financial coordinator for an exact quote.

The nationwide study already has about 2/3 of the 600 patients needed for the trial.  We are continuing to recruit patients to take advantage of this opportunity, and anticipate that enrollment for the study will close in a few months.

Here is a list of the main requirements patients need to qualify for the study:

  • Age 21- 35 years old
  • BMI (Body Mass Index) between 18-30 kg/m2
  • Regular menstrual cycle of 21 – 45 days
  • History of infertility and desire for pregnancy
  • Good ovarian reserve with an AMH (Anti-Mullerian Hormone) ≥ 5 (ng/mL)
  • No history of endometriosis stage III-IV, recurrent miscarriage, or previous poor response to a controlled ovarian stimulation cycle
  • Non-smoker

The eligibility requirements to participate have not changed since the start of the trial in October 2015. It is imperative for the integrity of a clinical trial and the data that is collected, to make sure that all patients meet the eligibility criteria. Some of this criteria can be managed by the patient such as weight, smoking and medications.

If a patient can stop smoking, lose weight to meet the BMI criteria, and discontinue certain medications (such as estrogen, progesterone, testosterone, birth control, steroids, DHEA and insulin sensitizers like metformin/ glucophage), this increases her likelihood of being able to participate. Certain other criteria are out of the control of the patient such as AMH level and other screening bloodwork.

If you meet the criteria above and are interested in participating in this research study, please email me at [email protected] to complete an application, or call the office to schedule a consult with Dr. John Park.

We look forward to seeing you!